Contingent of Local Farmers Will be in Attendance for a Discussion on Key Federal and State Issues Related to Renewable Fuel Production
MILTON, GA - (NewMediaWire) - August 5, 2019 - Attis Industries Inc. (NASDAQ: ATIS) (the "Company" or "Attis"), a diversified innovation and technology holding company, today announced that it will be hosting Congressman John Katko, Representative from New York’s 24th district in the United States House of Representatives, on August 6th at its recently acquired corn ethanol plant in Fulton, NY.
The Congressman’s visit is part of the Government Relations Speaking Series organized by the Manufacturers Association of Central New York (“MACNY”) for MACNY members. It will include a tour of the plant and a roundtable discussion on key federal and state issues related to renewable fuel production among other issues of concern to manufacturers in central New York. Of particular interest to Attis will be addressing the EPA’s continued approval of Small Refinery Exemptions (“SRE”) under the Renewable Fuel Standard. The current administration has significantly increased the number of SREs leading to demand destruction of nearly 2.5 billion gallons of renewable fuel. Attis will also discuss with Congressman Katko New York State’s goal of reaching net zero emissions by 2050 and how Attis’ corn ethanol facility and its future Greentech campus will play a significant role in decarbonizing the transportation sector.
“It is our belief that Attis is in an ideal position to assist New York in meeting its aggressive carbon reduction goals at our planned GreenTech campus,” stated Helen Petersen, Director of Corporate Policy and Governmental Affairs. “Attis is planning to invest $150 million to upgrade and expand its facilities to lower the carbon emissions of corn-based ethanol, future production of cellulosic ethanol from biomass as well as numerous other biobased products like carbon fiber and bioplastics. We welcome the opportunity to share our vision with Congressman Katko and encourage him to support market-based policies that allow for diverse technology solutions to our transportation challenges.”
Also, in attendance at the meeting will be numerous local farmers, all of whom are integral to the ongoing operations at the Fulton facility. The Fulton corn ethanol facility procures approximately 31 million bushels of corn annually for its operations, 50% of which is sourced within the state of New York and Attis appreciates the opportunity to thank the local farms who contribute to its success.
Greg Pilewicz, Attis Industries President, stated, “Our Fulton facility is the crown jewel in our renewable fuel production operations, and we believe its location in upstate New York is primed to take advantage of existing and future mandates to meet New York’s ambitious carbon reduction goals. With the continued support of the local farmers and a strong market for state manufactured fuels, Attis is poised to be the preeminent producer of sustainable fuels and products in the United States.”
Attis requests all press interested in attending the event to arrive at the Fulton Plant at 4pm EST. Congressman Katko and Attis’ management will be available for interviews then, before the tour begins.
Attis Industries Inc.
Attis Industries Inc. (NASDAQ: ATIS) is a holding company focused on developing and building businesses that play important roles in the new economy, which include renewable fuels, bio-based plastics, healthcare and communications infrastructure. We strive to encourage our employees to be entrepreneurs focused on innovation and technology. We will remain dynamic, persistent and motivated to our mission of winning. The growth of our company will rely on our integrity and our vision for the future. Attis Industries will continue to fulfill essential needs in healthcare, energy independence and digital communications. Today, each of these sectors provide high growth opportunities that collectively account for more than a third of our nations GDP. For more information, visit: www.attisind.com.
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. You can identify forward-looking statements by words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “should,” “would” or similar words. You should consider these statements carefully because they discuss our plans, targets, strategies, prospects and expectations concerning our business, operating results, financial condition and other similar matters. These statements are subject to certain risks, uncertainties, and assumptions, including, but not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, clinical studies and future product commercialization; and, the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies; the ability of the Company to continue to meet the listing requirements of NASDAQ; the ability of the Company to execute on a business plan that permits the technologies and innovations businesses to provide sufficient growth, revenue, liquidity and cash flows for sustaining the Company’s go-forward business and meeting any of its obligations under its indebtedness for borrowed money, and the risks identified and discussed under the caption “Risk Factors” in the Attis Annual Report on Form 10-K for the fiscal year ended December 31, 2017, filed with the Securities and Exchange Commission (the “SEC”) on April 16, 2018 and the other documents Attis files with the SEC from time to time. There will be events in the future, however, that Attis is not able to predict accurately or control. Attis’s actual results may differ materially from the expectations that Attis describes in its forward-looking statements. Factors or events that could cause Attis’s actual results to materially differ may emerge from time to time, and it is not possible for Attis to accurately predict all of them. Any forward-looking statement made by Attis in this press release speaks only as of the date on which Attis makes it. Attis undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Corporate Investor Relations: